Summit Therapeutics Inc. (SMMT) Financials

SMMT Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 491.3 million 77.3 million
Dec. 31, 2025 557.5 million 68.5 million
Sept. 30, 2025 194.6 million 51.6 million
June 30, 2025 237.8 million 47.4 million

SMMT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -92.9 million 55.2 million
Dec. 31, 2025 -75.8 million 83.0 million
Sept. 30, 2025 -69.2 million 97.2 million
June 30, 2025 -49.0 million 351.3 million

SMMT Net Income

No data available :(

SMMT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 454.1 million - 15.2 million
Dec. 31, 2025 529.5 million - 15.5 million
Sept. 30, 2025 177.3 million - 4.0 million
June 30, 2025 218.6 million - 4.1 million

SMMT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 775.5 million
Dec. 31, 2025 766.4 million
Sept. 30, 2025 744.4 million
June 30, 2025 743.4 million

SMMT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 185798 132.6 million 62.6 million -
Dec. 31, 2025 121714 147.3 million 77.6 million -
Sept. 30, 2025 52777 131.1 million 103.1 million -
June 30, 2025 52777 151.6 million 262.6 million -

SMMT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 44000
Dec. 31, 2025 - 4355
Sept. 30, 2025 - -
June 30, 2025 - 37000

SMMT Revenue by Segment
Graph available only for paid members. Upgrade to see it.

SMMT

Price: $14.32

52 week price:
13.05
30.98

Earnings Per Share: -1.59 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 252593

Ebitda: -3.9 million

Market Capitalization: 11.7 billion

Links: